Cargando…

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications

PURPOSE: Cardiovascular disease (CVD) is a macrovascular complication in patients with type 2 diabetes mellitus (T2DM). To date, glycemic control profiles of antidiabetic drugs in cardiovascular (CV) complications have not been clearly elucidated. Therefore, this study was conducted retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huri, Hasniza Zaman, Ling, Doris Yew Hui, Ahmad, Wan Azman Wan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547657/ https://www.ncbi.nlm.nih.gov/pubmed/26316711 http://dx.doi.org/10.2147/DDDT.S87294

Ejemplares similares

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Syed Ikmal, Sharifah Intan Qhadijah, et al.
Publicado: (2013)

Retinol-Binding Protein-4—A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes?
por: Perumalsamy, Sangeetha, et al.
Publicado: (2021)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction
por: Lin, Shu Ning, et al.
Publicado: (2020)

Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2015)

Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study
por: Zaman Huri, Hasniza, et al.
Publicado: (2013)

Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects
por: Ahmed, Radwan H., et al.
Publicado: (2016)

Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus: A Review of Current Evidence and Challenges
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2017)

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities
por: Huri, Hasniza Zaman, et al.
Publicado: (2017)

Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Drug-related problems in patients with rheumatoid arthritis
por: Ma, Shu Ning, et al.
Publicado: (2019)

Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design
por: Elnaem, Mohamed Hassan, et al.
Publicado: (2019)

Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review
por: Almualm, Yasmin, et al.
Publicado: (2015)

Cardiovascular Outcomes with Finerenone According to Glycemic Status at Baseline and Prior Treatment with Newer Antidiabetics among Patients with Type 2 Diabetes Mellitus
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention
por: Mokhtar, Fadzlin Mohd, et al.
Publicado: (2021)

Differences in glycemic control across world regions: a post-hoc analysis in patients with type 2 diabetes mellitus on dual antidiabetes drug therapy
por: Brath, H, et al.
Publicado: (2016)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients
por: Wen, Wei-Lun, et al.
Publicado: (2022)

Periodontal disease and type I diabetes mellitus: Associations with glycemic control and complications
por: Meenawat, Ajita, et al.
Publicado: (2013)

Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
por: Tee, Khim Boon, et al.
Publicado: (2022)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022)

Association of MG53 with presence of type 2 diabetes mellitus, glycemic control, and diabetic complications
por: Andaç, Burak, et al.
Publicado: (2023)

Changes in Antidiabetic Drug Prescription and Glycemic Control Trends in Elderly Patients with Type 2 Diabetes Mellitus from 2005-2013: An Analysis of the National Center Diabetes Database (NCDD-03)
por: Yamamoto-Honda, Ritsuko, et al.
Publicado: (2017)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
por: Schubert, Mario, et al.
Publicado: (2020)

Factors affecting glycemic control in diabetes mellitus complicated by autoimmune pancreatitis
por: Harai, Nozomi, et al.
Publicado: (2022)

Factors that Correlate with Poor Glycemic Control in Type 2 Diabetes Mellitus Patients with Complications
por: Haghighatpanah, Mohammad, et al.
Publicado: (2018)

The Association of Obesity and Microvascular Complications with Glycemic Control in Patients with Type 2 Diabetes Mellitus
por: Bijelic, Radojka, et al.
Publicado: (2020)

Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review
por: Hassanein, Mohammed M., et al.
Publicado: (2023)

Therapeutic Effects of Vitamin D on Vaginal, Sexual, and Urological Functions in Postmenopausal Women
por: Hassanein, Mohammed M., et al.
Publicado: (2023)

Effects of Fruit and Vegetable Polyphenols on the Glycemic Control and Metabolic Parameters in Type 2 Diabetes Mellitus: A Review
por: Zin, Che Anis Jauharah Che Mohd, et al.
Publicado: (2022)

Predictors of poor glycemic control among type 2 diabetes mellitus patients treated with antidiabetic medications: A cross-sectional study in China
por: Wang, Jingqing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8pgibiu298dhp2ehgl6rv2bhp5